Most recently, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to some wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger https://allant986qux9.wikiexcerpt.com/user